Overview

The Effects of Low-Dose Versus High-Dose Intravenous IRON Therapy With Ferric DerisomaltOSE in Patients With Chronic Heart Failure and Iron Deficiency

Status:
RECRUITING

Trial end date:
2026-12-21

Target enrollment:

Participant gender:

Summary

This study will address whether intravenous (IV) iron repletion with a more intensive target will provide greater benefits in improving exercise capacity for patients with chronic heart failure and iron deficiency. One group of participants will receive a high-dose IV iron regimen with a more intensive target, and the other group will receive a low-dose IV iron regimen with a less intensive target.

Phase:

PHASE4

Details

Lead Sponsor:

China-Japan Friendship Hospital

Treatments:

ferric derisomaltose